Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Drug-Induced ED

Medications That Cause Erectile Dysfunction

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Class of adverse drug effects (varies by agent)

Reference only. Not medical advice.

What can go wrong

The key risk is misattribution: failing to recognize a drug cause leads to unnecessary ED treatment while the trigger persists. Patients should never stop prescribed cardiovascular or psychiatric medication on their own; substitutions (e.g., to ARBs, nebivolol, or bupropion) must be physician-guided. Some effects, notably with finasteride (post-finasteride syndrome) and SSRIs (PSSD), are reported to persist after stopping in a subset of users, though causation and frequency are debated.

This is something to take to a clinician. The Atlas can tell you what is known about drug-induced ed in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

A large share of erectile dysfunction is iatrogenic, caused or worsened by common prescription and recreational drugs. Frequent culprits include certain antihypertensives (thiazides, non-selective beta-blockers), SSRIs and other antidepressants, 5-alpha-reductase inhibitors (finasteride), antipsychotics, anti-androgens, opioids, and heavy alcohol or recreational drug use. Recognizing and, where possible, substituting the offending agent is a first-line, often-overlooked step in ED management.

Sometimes the cause of ED is in the medicine cabinet.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Medication review in new-onset ED
  • Identifying reversible iatrogenic causes
  • Guiding antihypertensive/antidepressant substitution

How it works

Mechanisms vary by drug class: antihypertensives reduce penile perfusion or sympathetic/endothelial signaling; SSRIs raise serotonergic tone that blunts libido and orgasm; 5-alpha-reductase inhibitors lower DHT affecting libido and erectile tissue; opioids and antipsychotics suppress gonadal axis and dopaminergic drive; alcohol and recreational drugs impair neurovascular and hormonal function.

What has to be monitored

The bloodwork this needs, and the reason it belongs with a clinician rather than a website.

  • Full medication and substance review at ED onset
  • Reassessment of erectile function after any drug substitution
  • Coordination with prescribing clinicians (cardiology/psychiatry)

What people get wrong

  • Often saidED is always about aging or psychology

    ActuallyMedications are a leading and reversible cause that is frequently missed in routine care.

  • Often saidYou should stop your blood pressure or antidepressant drug if it causes ED

    ActuallyStopping unsupervised is dangerous; substitution to a lower-risk agent should be done with a physician.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Antihypertensives
Thiazide diuretics, non-selective beta-blockers higher risk
Antidepressants
SSRIs/SNRIs (sexual side effects common)
5-ARIs
Finasteride/dutasteride (libido, ED, possible persistence)
Other
Opioids, antipsychotics, anti-androgens, alcohol, recreational drugs

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Drug-Induced ED. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Antihypertensive class and sexual function reviews2000s-2010s

    Thiazides and non-selective beta-blockers most linked to ED; ARBs and nebivolol relatively favorable

  • SSRI sexual side-effect meta-analyses2000s

    High rates of treatment-emergent sexual dysfunction across SSRIs/SNRIs

  • Finasteride sexual adverse-event reports2010s

    Reports of persistent sexual dysfunction prompted label updates in some regions